Goodwill and Intangible Assets (Tables)

6 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Components of Goodwill by Business Segment

The changes in the Company’s goodwill by reportable segment for the six months ended March 31, 2023 are as follows (in thousands):

	Life Sciences		Life Sciences
	Products		Services		Total
Balance, at September 30, 2022	$	154,612	$	359,011	$	513,623
Acquisitions		228,851		—		228,851
Currency translation adjustments		47,998		22		48,020
Balance, at March 31, 2023	$	431,461	$	359,033	$	790,494

Schedule of intangible assets

The components of the Company’s identifiable intangible assets as of March 31, 2023 and September 30, 2022 are as follows (in thousands):

	March 31, 2023						September 30, 2022
			Accumulated		Net Book				Accumulated		Net Book
	Cost		Amortization		Value		Cost		Amortization		Value
Patents	$	8,996	$	8,911	$	85	$	1,225	$	1,106	$	119
Completed technology		258,146		85,726		172,420		99,525		37,991		61,534
Trademarks and trade names		8,848		2,865		5,983		400		41		359
Non-competition agreements		731		553		178		681		439		242
Customer relationships		321,024		176,432		144,592		246,949		130,802		116,147
Other intangibles		896		227		669		202		202		—
	$	598,641	$	274,714	$	323,927	$	348,982	$	170,581	$	178,401

Schedule of Future Amortization Expense

Estimated future amortization expense for the intangible assets for the remainder of fiscal year 2023, the subsequent four fiscal years and thereafter is as follows (in thousands):

2023	$	24,217
2024		50,542
2025		49,151
2026		45,754
2027		37,573
Thereafter		116,690
Total	$	323,927